The UAB CFAR Sequencing Core, which is comprised of a DNA Sequencing Facility and a Training and Analysis Facility, has been in operation for the past nine years and has provided users with a state-of-the-art automated sequencing and computer analyses capabilities. Major goals of the Sequence and Analysis Core are: 1. To provide state-of-the-art automated DNA sequencing capabilities to AIDS Center members through the availability and maintenance of dedicated Applied Biosystems DNA Sequencers and an Affymetrix GeneChip DNA Sequencing System (DNA Sequencing Facility). 2. To provide technical support and training in cycle (ABI) and GeneChip (Affymetrix) sequencing methodologies (DNA Sequencing Facility). 3. To maintain and update a comprehensive set of nucleic acids and protein sequence analysis programs from the Wisconsin Genetics Computer Group for AIDS Center members on a campus-wide network (Training and Analysis Facility). 4. To provide technical support and training in the use of these nucleic acid and protein sequence analysis programs (Training and Analysis Facility). In the past budget period, the Sequencing Core has supported over 168 funded grants and contracts of 148 CFAR users. The DNA Sequencing Facility generated over two million base pairs of primary sequence and $118,657 of charge-backs. The Training and Analysis Facility was used by over 400 UAB investigators and generated $115,439 of charge-backs. Over 50 currently funded projects as well as several new grants are absolutely dependent on the availability of automated DNA sequencing and sophisticated sequence analysis. Support of the DNA Sequence and Analysis Core is thus instrumental for the continuing success of the numerous HIV pathogenesis, vaccine and drug studies currently conducted at UAB.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
3P30AI027767-14S1
Application #
6506663
Study Section
Project Start
2001-03-01
Project End
2002-02-28
Budget Start
Budget End
Support Year
14
Fiscal Year
2001
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Merlin, Jessica S; Long, Dustin; Becker, William C et al. (2018) Brief Report: The Association of Chronic Pain and Long-Term Opioid Therapy With HIV Treatment Outcomes. J Acquir Immune Defic Syndr 79:77-82
Hamilton, Jennie A; Wu, Qi; Yang, PingAr et al. (2018) Cutting Edge: Intracellular IFN-? and Distinct Type I IFN Expression Patterns in Circulating Systemic Lupus Erythematosus B Cells. J Immunol 201:2203-2208
Stafman, Laura L; Mruthyunjayappa, Smitha; Waters, Alicia M et al. (2018) Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma. Oncotarget 9:22665-22679
Yang, Zhenhua; Shah, Kushani; Busby, Theodore et al. (2018) Hijacking a key chromatin modulator creates epigenetic vulnerability for MYC-driven cancer. J Clin Invest 128:3605-3618
Nag, Mukta; De Paris, Kristina; E Fogle, Jonathan (2018) Epigenetic Modulation of CD8? T Cell Function in Lentivirus Infections: A Review. Viruses 10:
Barr, Fiona D; Ochsenbauer, Christina; Wira, Charles R et al. (2018) Neutrophil extracellular traps prevent HIV infection in the female genital tract. Mucosal Immunol 11:1420-1428
Holdbrooks, Andrew T; Britain, Colleen M; Bellis, Susan L (2018) ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor. J Biol Chem 293:1610-1622
Williams, Adele P; Waters, Alicia M; Stewart, Jerry E et al. (2018) A novel retinoid X receptor agonist, UAB30, inhibits rhabdomyosarcoma cells in vitro. J Surg Res 228:54-62
Dixit, Saurabh; Sahu, Rajnish; Verma, Richa et al. (2018) Caveolin-mediated endocytosis of the Chlamydia M278 outer membrane peptide encapsulated in poly(lactic acid)-Poly(ethylene glycol) nanoparticles by mouse primary dendritic cells enhances specific immune effectors mediated by MHC class II and CD4+ T cells. Biomaterials 159:130-145
Bengtson, Angela M; Pence, Brian W; Eaton, Ellen F et al. (2018) Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015. Antivir Ther 23:363-372

Showing the most recent 10 out of 955 publications